Drug-Eluting Balloon Registry in Routine Clinical Practice
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorSeung-Jung Park
About this trial
The purpose of this study is to evaluate long-term effectiveness and safety of patients with coronary disease treated with drug eluting balloon in real world practice.
Eligibility criteria
Qualifiers
After pre dilatation residual stenosis 30% and less and also without vessel dissection interrupted blood flow
Age 20 and more
Treated with Balloon angioplasty
Signed informed consent and agreed to follow protocol
Disqualifiers
Allergy to paclitaxel, antiplatelet
History of side effect to heparin, aspirin, thienopyridines
History of bleeding tendency, coagulation disorder, blood transfusion reaction
Trial design
Treatments tested in this trial
- Balloon angioplasty
Treatment groups
1,500 Participants
are divided into 1 treatment groupSponsors and collaborators
Seung-Jung Park
Lead sponsor
Asan Medical Center
Sponsor institution
CardioVascular Research Foundation, Korea
Collaborator
B. Braun Korea Co., Ltd.
Collaborator
Source ClinicalTrials.gov